PomDoctor Begins ADR Termination; Ordinary Shares to Trade on Nasdaq Oct 21 After 10:1 Consolidation
POM sits 28% above its 52-week low of $0.5 on light trading volume (0.4× avg).
Summary
PomDoctor has formally begun terminating its ADR program, with ADSs converting into Class A ordinary shares and a 10-to-1 consolidation taking effect before the October 21 Nasdaq open. The move follows the October 9 delisting determination and a going-concern warning, and does not by itself resolve either.
Key Events · Corporate Governance and Compliance · POM
-
ADR Program Termination Commenced
The ADR program and Deposit Agreement with Citibank, N.A. terminate prior to the market open on October 21, 2026; ADSs are mandatorily cancelled and exchanged for Class A ordinary shares.
-
10-to-1 Consolidation and Exchange Ratio
Every ten ordinary shares of each class consolidate into one; combined with the Mandatory Exchange, each holder of ten ADSs receives three post-consolidation Class A ordinary shares.
-
Direct Nasdaq Listing October 21
Class A ordinary shares are expected to trade on Nasdaq under symbol 'POM' with new CUSIP G7166T112 starting October 21, 2026; TranShare Corporation is U.S. transfer agent.
-
Delisting and Going-Concern Backdrop
Follows the October 9 Nasdaq Staff Delisting Determination after the ADS closed below $1.00 for 30 consecutive business days, and the September 29 disclosure of a RMB238.2M H1 2026 net loss with a going-concern warning.
Analysis · POM · Trade & Services
This is the mechanical execution of the restructuring shareholders approved on September 30: the ADR program dies before the open on October 21, ADSs are mandatorily cancelled, and every ten ADSs convert into three post-consolidation Class A ordinary shares. The 10-to-1 consolidation is the company's attempt to lift its per-share price back above Nasdaq's $1.00 minimum after the October 9 delisting determination, but it does not fix the underlying problem — a RMB238.2M H1 2026 net loss and a going-concern warning disclosed September 29. The new detail worth noting is the exchange ratio: ten ADSs become three ordinary shares, so holders end up with 0.3 of a share per ADS, not the full 0.1 implied by the consolidation alone, because the ADS ratio itself is being reset. Trading under 'POM' with CUSIP G7166T112 begins October 21; whether the listing survives depends on the price holding above $1.00 and on the company closing the US$30M raise it announced September 10.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, POM was trading at $0.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $4.9M. The 52-week trading range was $0.50 to $115.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.